Parameters Group 28 Days
Hb (g/dl) I 14.22 ± 0.158a
  II 13.87 ± 0.344a
  III 12.41 ± 0.191b
  IV 10.44 ± 0.260c
PCV (%) I 43.66 ± 0.279a
  II 42.36 ± 0.352b
  III 41.13 ± 0.285c
  IV 34.85 ± 0.190d
TEC (millions/cumm) I 10.16 ± 0.205a
  II 9.31 ± 0.247b
  III 4.54 ± 0.341c
  IV 3.81 ± 0.238c
TLC (thousand/cumm) I 9.51 ± 0.229a
  II 8.84 ± 0.215b
  III 7.08 ± 0.136c
  IV 4.30 ±0.143d
MCV (fl) I 87.30 ± 0.337d
  II 89.29 ± 0.296c
  III 93.06 ± 0.201a
  IV 91.94 ± 0.263b
MCHC (g/dl) I 33.12 ± 0.140a
  II 28.83 ± 0.181c
  III 30.57 ± 0.133b
  IV 30.54 ± 0.291b
MCH (pg) I 23.53 ± 0.178c
  II 24.52 ± 0.292b
  III 28.58 ± 0.162a
  IV 28.04 ± 0.153a
Values bearing different superscripts in a column differed significantly (P ≤ 0.01), Values were expressed as mean ± SE, n=5
Table 3: Effect of acetamiprid on hematological profile in mice after daily oral administration for 28 days.